Norwegian version of this page

Fulgencio Ruso Julve

Image of Fulgencio Ruso Julve
Room Department of Pharmacology, A2.3051
Username
Visiting address Sognsvannsveien 20 Rikshospitalet 0372 Oslo
Postal address Postboks 1057 Blindern 0316 Oslo
Tags: Immunology, antibodies, biodistribution

Publications

Tulika, T., Pedersen, R. W., Rimbault, C., Ahmadi, S., Rivera-de-Torre, E., Fernández-Quintero, M. L., Loeffler, J. R., Bohn, M. F., Ljungars, A., Ledsgaard, L., Voldborg, B. G., Ruso-Julve, F., Andersen, J. T., & Laustsen, A. H. (2023). Phage display assisted discovery of a pH-dependent anti-α-cobratoxin antibody from a natural variable domain library. Protein science: a publication of the Protein Society, 32(12), e4821. https://doi.org/10.1002/pro.4821 (Contribution)

Wade, J., Rimbault, C., Ali, H., Ledsgaard, L., Rivera-de-Torre, E., Abou Hachem, M., Boddum, K., Mirza, N., Bohn, M. F., Sakya, S. A., Ruso-Julve, F., Andersen, J. T., & Laustsen, A. H. (2022). Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes. Bioconjugate chemistry, 33(8), 1494–1504. https://doi.org/10.1021/acs.bioconjchem.2c00220 (*Co-corresponding)

García-Díaz, N., Casar, B., Alonso-Alonso, R., Quevedo, L., Rodríguez, M., Ruso-Julve, F., Esteve-Codina, A., Gut, M., Gru, A. A., González-Vela, M. C., Gut, I., Rodriguez-Peralto, J. L., Varela, I., Ortiz-Romero, P. L., Piris, M. A., & Vaqué, J. P. (2022). PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression. The Journal of investigative dermatology, 142(5), 1391–1400.e15. https://doi.org/10.1016/j.jid.2021.09.024 (Contribution)

Ruso-Julve, F., Pombero, A., Pilar-Cuéllar, F., García-Díaz, N., Garcia-Lopez, R., Juncal-Ruiz, M., Castro, E., Díaz, Á., Vazquez-Bourgón, J., García-Blanco, A., Garro-Martinez, E., Pisonero, H., Estirado, A., Ayesa-Arriola, R., López-Giménez, J., Mayor, F., Jr, Valdizán, E., Meana, J., Gonzalez-Maeso, J., Martínez, S., … Crespo-Facorro, B. (2019). Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics. Translational psychiatry, 9(1), 306. https://doi.org/10.1038/s41398-019-0647-7. (*First author).

Gilabert-Juan, J., López-Campos, G., Sebastiá-Ortega, N., Guara-Ciurana, S., Ruso-Julve, F., Prieto, C., Crespo-Facorro, B., Sanjuán, J., & Moltó, M. D. (2019). Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia. Brain, behavior, and immunity, 80, 909–915. https://doi.org/10.1016/j.bbi.2019.05.015 (Contribution)

Sainz, J., Prieto, C., Ruso-Julve, F., & Crespo-Facorro, B. (2018). Blood Gene Expression Profile Predicts Response to Antipsychotics. Frontiers in molecular neuroscience, 11, 73. https://doi.org/10.3389/fnmol.2018.00073 (Third author)

Lopez-Gimenez, J. F., de la Fuente Revenga, M., Ruso-Julve, F., Saunders, J. M., Moreno, J. L., Crespo-Facorro, B., & González-Maeso, J. (2017). Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy. Schizophrenia research, 189, 217–218. https://doi.org/10.1016/j.schres.2017.02.005 (Third author)
Published Nov. 11, 2021 12:33 PM - Last modified Jan. 12, 2024 2:18 PM